Chargement en cours...
Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment
Specific prophylactic migraine treatments are urgently needed because of the unmet needs of many migraine patients. Antibodies targeting calcitonin gene-related peptide (CGRP) or its receptor have recently shown efficacy in episodic and chronic migraine and will be available soon.
Enregistré dans:
| Publié dans: | Genome Med |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5824555/ https://ncbi.nlm.nih.gov/pubmed/29471874 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13073-018-0524-7 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|